Position in MYGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,149,825
+$2,796,236 QoQ
Shares Held
901,896
+72.4% QoQ
Ownership
0.943%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 196 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $6,400,081,910 across 33 Diagnostics & Research names. MYGN ranks #27 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,895,265 | $1,952,930,056 | |
| 2 | DHR |
Danaher Corp /De/
|
5,217,586 | $993,845,777 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,935,133 | $410,151,436 | |
| 4 | WAT |
Waters Corp /De/
|
839,592 | $314,880,579 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
1,172,586 | $265,930,776 | |
| 6 | ILMN |
Illumina, Inc.
|
1,455,287 | $255,883,110 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
476,998 | $251,110,825 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
188,505 | $240,817,020 |
All Filings in MYGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,149,825 | 901,896 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,353,589 | 523,020 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $5,332,484 | 867,071 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,531,874 | 488,503 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,211,863 | 416,547 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,338,351 | 2,631,156 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $32,941,124 | 2,402,708 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $79,393,171 | 2,898,619 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $66,179,828 | 2,705,635 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $56,386,323 | 2,644,762 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $57,150,066 | 2,985,897 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $48,084,661 | 2,997,797 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $68,863,627 | 2,970,821 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $79,747,867 | 3,432,969 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $38,440,629 | 2,649,251 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $54,452,466 | 2,853,903 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $49,775,295 | 2,739,422 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $69,531,937 | 2,759,204 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $68,705,146 | 2,489,317 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $83,538,263 | 2,587,125 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $75,976,435 | 2,484,514 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $83,612,684 | 2,745,901 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $51,354,233 | 2,597,584 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $27,454,791 | 2,105,429 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $23,784,547 | 2,097,403 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $17,949,416 | 1,254,327 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||